Rho-kinase inhibitors
CA 2441492 C · Owner: Weber, Olaf · Inventors: Weber, Olaf; Bankston, Donald; Liu, Xiao-Gao
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds (see formula I), wherein A, B, X, Y, R1 R2, R3, R4, R5, a, b, c and p are as defined herein and , derivatives thereof, their synthesis and their use as Rho-kinase inhibitors. The , compounds of the present invention are useful for inhibiting tumor growth treating , erectile dysfunction and treating other indications mediated by Rho-kinase e.g. , coronary heart disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 22, 2002 and granted August 9, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 22, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 22, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.